Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.

Chapman WC, Singla N, Genyk Y, McNeil JW, Renkens KL Jr, Reynolds TC, Murphy A, Weaver FA.

J Am Coll Surg. 2007 Aug;205(2):256-65. Epub 2007 Jun 27.

PMID:
17660072
2.

Protecting the privacy of third-party information: recommendations for social and behavioral health researchers.

Lounsbury DW, Reynolds TC, Rapkin BD, Robson ME, Ostroff J.

Soc Sci Med. 2007 Jan;64(1):213-22. Epub 2006 Oct 17.

PMID:
17049702
3.

Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.

Lovejoy AE, Reynolds TC, Visich JE, Butine MD, Young G, Belvedere MA, Blain RC, Pederson SM, Ishak LM, Nugent DJ.

Blood. 2006 Jul 1;108(1):57-62. Epub 2006 Mar 23.

4.

Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers: a randomized, placebo-controlled, double-blind, multi-dose study.

Visich JE, Zuckerman LA, Butine MD, Gunewardena KA, Wild R, Morton KM, Reynolds TC.

Thromb Haemost. 2005 Oct;94(4):802-7.

PMID:
16270634
5.

Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers.

Reynolds TC, Butine MD, Visich JE, Gunewardena KA, MacMahon M, Pederson S, Bishop PD, Morton KM.

J Thromb Haemost. 2005 May;3(5):922-8.

6.

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.

Flotte TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S, Conrad CK, Brass-Ernst L, Humphries M, Sullivan K, Wetzel R, Taylor G, Carter BJ, Guggino WB.

Hum Gene Ther. 2003 Jul 20;14(11):1079-88.

PMID:
12885347
7.

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.

Wagner JA, Nepomuceno IB, Messner AH, Moran ML, Batson EP, Dimiceli S, Brown BW, Desch JK, Norbash AM, Conrad CK, Guggino WB, Flotte TR, Wine JJ, Carter BJ, Reynolds TC, Moss RB, Gardner P.

Hum Gene Ther. 2002 Jul 20;13(11):1349-59.

PMID:
12162817
8.

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease.

Aitken ML, Moss RB, Waltz DA, Dovey ME, Tonelli MR, McNamara SC, Gibson RL, Ramsey BW, Carter BJ, Reynolds TC.

Hum Gene Ther. 2001 Oct 10;12(15):1907-16.

PMID:
11589832
9.

Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer.

Yoo GH, Hung MC, Lopez-Berestein G, LaFollette S, Ensley JF, Carey M, Batson E, Reynolds TC, Murray JL.

Clin Cancer Res. 2001 May;7(5):1237-45.

10.

Repeated delivery of adeno-associated virus vectors to the rabbit airway.

Beck SE, Jones LA, Chesnut K, Walsh SM, Reynolds TC, Carter BJ, Askin FB, Flotte TR, Guggino WB.

J Virol. 1999 Nov;73(11):9446-55.

11.

A high-throughput hybridization method for titer determination of viruses and gene therapy vectors.

Atkinson EM, Debelak DJ, Hart LA, Reynolds TC.

Nucleic Acids Res. 1998 Jun 1;26(11):2821-3.

13.

Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.

Conrad CK, Allen SS, Afione SA, Reynolds TC, Beck SE, Fee-Maki M, Barrazza-Ortiz X, Adams R, Askin FB, Carter BJ, Guggino WB, Flotte TR.

Gene Ther. 1996 Aug;3(8):658-68.

PMID:
8854091
14.

In vivo model of adeno-associated virus vector persistence and rescue.

Afione SA, Conrad CK, Kearns WG, Chunduru S, Adams R, Reynolds TC, Guggino WB, Cutting GR, Carter BJ, Flotte TR.

J Virol. 1996 May;70(5):3235-41.

15.

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients.

Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, Manley SA, Lupton SD, Overell RW, Reynolds TC, Corey L, Greenberg PD.

Nat Med. 1996 Feb;2(2):216-23.

PMID:
8574968
16.

Integration of murine leukemia virus DNA depends on mitosis.

Roe T, Reynolds TC, Yu G, Brown PO.

EMBO J. 1993 May;12(5):2099-108.

17.

TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.

Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J.

Cell. 1991 Aug 23;66(4):649-61.

PMID:
1831692
18.

Micrococcal nuclease digestion study of spermidine-condensed DNA.

Marx KA, Reynolds TC.

Int J Biol Macromol. 1989 Aug;11(4):241-8.

PMID:
2489088
21.

Clonal T-cell populations in pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease).

Weiss LM, Wood GS, Ellisen LW, Reynolds TC, Sklar J.

Am J Pathol. 1987 Mar;126(3):417-21.

24.

The insulin receptor as a universal marker of activated lymphocytes.

Helderman JH, Reynolds TC, Strom TB.

Eur J Immunol. 1978 Aug;8(8):589-95. No abstract available.

PMID:
81134

Supplemental Content

Loading ...
Support Center